Skip to main content

Table 4 Cost, quality-adjusted life-years (QALY), and incremental cost-effectiveness ratio (ICER) values

From: Cost-effectiveness analysis of advanced radiotherapy techniques for post-mastectomy breast cancer patients

 

Cost ($)

QALY

ICER ($/QALY, relative to the adjacent cost-effective technique)

SOC

15,352

9.214

–

STD-VMAT

19,131

9.33

32,617

TOMO

20,267

9.314

Dominated by STD-VMAT

IMRT

20,543

9.404

19,081

MA-VMAT

20,617

9.365

Dominated by IMRT

NC-VMAT

20,633

9.402

Dominated by IMRT

MIXED

22,985

9.385

Dominated by IMRT

IMPT

38,145

9.52

151,741